2017 Datamonitor Healthcare Content Calendar

Datamonitor Healthcare Pharma intelligence | informa

2017 Content Calendar Published February 2017

Datamonitor Healthcare provides up-to-date insights and analysis that you can trust. Disease ReportsEpidemiology and patient-based market forecasts, treatment algorithms, and marketed and pipeline drug analyses. Market assumptions are supported by in-depth and current primary research data, with sample sizes of over 200 specialists per indication.

Drug Overviews Comprehensive overviews of marketed products and pipeline candidates across a full range of disease indications.

Company Profiles Detailed analysis of the pipelines, performances, & future prospects for top pharma and emerging pharma and biotech companies.

Trends & Market Access Reports: Market access, hot topics, and key trends shaping the industry that impact pricing and reimbursement, competitive dynamics, growth markets, and value chain issues.

Q1 January – March Indication/Report Title Therapeutic Area/Report Type Crohn’s Disease Immunology and Inflammation Systemic Lupus Erythematosus Immunology and Inflammation Influenza Vaccines Infectious Diseases and Vaccines Breast cancer: HR+/HER2- Oncology Breast cancer: Triple-negative Oncology Glioblastoma Oncology Chronic Lymphocytic Leukemia Oncology Non-Small Cell Lung Cancer Oncology Diabetes Type 2 Cardiovascular and Metabolic Acute Decompensated Heart Failure Cardiovascular and Metabolic Osteoporosis Cardiovascular and Metabolic Diabetic Nephropathy Cardiovascular and Metabolic Non-Alcoholic Steatohepatitis (NASH) Cardiovascular and Metabolic Parkinson’s Disease Central Nervous System Social Media in Pharma Trends and Market Access Mid Pharma Licensing and M&A Trends, 2011–16 Trends and Market Access Big Pharma Licensing Trends, 2011-16 Trends and Market Access Biosimilars Market Access in the US Trends and Market Access Biosimilars Access in the EU Trends and Market Access Integrated delivery networks in the US Trends and Market Access Immuno-oncology deal trends, 2011-15 Trends and Market Access Value-based reimbursement in the US Trends and Market Access Johnson & Johnson Company Novartis Company Bristol-Myers Squibb Company AbbVie Company Pfizer Company Eli Lilly Company Roche Company Amgen Company Novo Nordisk Company Merck & Co Company

Datamonitor Healthcare Pharma intelligence | informa

AstraZeneca Company Gilead Company GlaxoSmithKline Company Sanofi Company Bayer Company Teva Company Biogen Company Celgene Company Allergan Company Lundbeck Company Actelion Company Shire Company UCB Company Merck KGaA Company Boehringer Ingelheim Company

Q2 April – June Indication/Report Title Therapeutic Area/Report Type Atopic dermatitis Immunology and Inflammation Ulcerative colitis Immunology and Inflammation Pneumococcal vaccines Infectious Diseases and Vaccines Chronic Obstructive Pulmonary Disease (COPD) Respiratory Idiopathic Pulmonary Fibrosis Respiratory Acute Myeloid Leukemia Oncology Hepatocellular Carcinoma Oncology Bladder Cancer Oncology Ovarian Cancer Oncology Lymphoma Pricing and Reimbursement Oncology Pulmonary Hypertension Cardiovascular and Metabolic Dyslipidemia Cardiovascular and Metabolic Diabetes Type 1 Cardiovascular and Metabolic Venous Thromboembolism (VTE) Cardiovascular and Metabolic Stroke Prevention in Atrial Fibrillation (SPAF) Cardiovascular and Metabolic Bipolar Disorder Central Nervous System Epilepsy Central Nervous System New Data Strategies to Improve R&D Efficiency Trends and Market Access Early Market Access Pathways Trends and Market Access Big Pharma Diversification Strategies Trends and Market Access Trends in Generics in the US, Japan and five major EU Markets Trends and Market Access Biosimilars in Emerging Markets Trends and Market Access Payer Pharma Partnerships Trends and Market Access Use of Real-World Evidence Trends and Market Access Biosimilars Trial Strategies Trends and Market Access Lifecycle Management Strategies Trends and Market Access

Datamonitor Healthcare Pharma intelligence | informa

Daiichi Sankyo Company Dainippon Sumitomo Company Astellas Company Takeda Company Otsuka Company Eisai Company Mitsubishi Tanabe Company Shionogi Company

Q3 July – September Indication/Report Title Therapeutic Area/Report Type HIV Infectious Diseases and Vaccines Dengue vaccines Infectious Diseases and Vaccines Meningococcal vaccines Infectious Diseases and Vaccines Asthma Respiratory Cystic fibrosis Respiratory Colorectal cancer Oncology Head and neck cancer Oncology Multiple Myeloma Oncology Chronic myeloid leukemia Oncology Leukemia Pricing and Reimbursement Oncology Age-related macular degeneration Pricing & Reimbursement Central Nervous System Depression Central Nervous System Obesity Cardiovascular and Metabolic Chronic heart failure (CHF) Cardiovascular and Metabolic Diabetic Nephropathy Cardiovascular and Metabolic Stroke Cardiovascular and Metabolic Orphan drug Pricing and Reimbursement Trends and Market Access

The Future of Healthcare Reform and Drug Pricing in the US Trends and Market Access

The Evolving Landscape in Oncology Pricing and Reimbursement

Trends and Market Access

Trends in Regenerative Medicine Trends and Market Access Pharma Product Portfolio Analysis Trends and Market Access Biosimilars Product Class Analysis Trends and Market Access

Q4 October – December Indication/Report Title Therapeutic Area/Report Type Axial Spondyloarthritis Immunology and Inflammation Rheumatoid Arthritis Immunology and Inflammation

Datamonitor Healthcare Pharma intelligence | informa

Psoriasis Immunology and Inflammation Retina Disorders Immunology and Inflammation Inflammatory Bowel Disease Pricing and Reimbursement Immunology and Inflammation Hepatitis B Infectious Diseases and Vaccines Hepatitis C Infectious Diseases and Vaccines Respiratory Syncytial virus (RSV) vaccines Infectious Diseases and Vaccines Chronic Obstructive Pulmonary Disease (COPD) Respiratory Gastric Cancer Oncology Melanoma Oncology Prostate Cancer Oncology Renal Cell Cancer Oncology Alzheimer’s Disease Central Nervous System Multiple Sclerosis Central Nervous System Schizophrenia Central Nervous System Hemophilia Cardiovascular and Metabolic Acute Coronary Syndrome Cardiovascular and Metabolic Biosimilars Physician and KOL Insights Trends and Market Access Biosimilars ROI Analysis Trends and Market Access

Datamonitor Healthcare Pharma intelligence | informa

The best coverage.The best forecasts.The best analysts.The best support.The Best of Health.

Introducing The New Datamonitor Healthcare.

We’ve quadrupled our business intelligence which covers more than 90% of prescription medicines in the major markets. Our forecasts are tailored to your needs as events occur and are powered by a new forecasting tool built in collaboration with a leading analytics technology provider. We’ve increased our global analyst resources by 300%, and Live Support replies to your queries in real time, not hours, for the fastest support in the market.

We’ve just made strategic investments in Datamonitor Healthcare to give you the best of health.

Discover the best of health.Visit https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare to tour the new Datamonitor Healthcare with one of our representatives. Request a live demo and see how The Best of Health supports smarter, faster decision-making.